GeriPal

JANUARY 23, 2025

Today, we explore four fascinating studies highlighting innovative approaches to reducing medication use and improving patient outcomes. Patients received brochures detailing the risks of gabapentinoids, nonpharmacologic alternatives, and a proposed deprescribing regimen (see here for the brochure ). in the usual care group.

Specialization 118

Specialization IT Patient-Centered Medical 118

GeriPal

AUGUST 4, 2022

My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. But how to talk to patients about the risk and benefits when starting. Eric: Yeah.

Specialization 103

Specialization Medical Patient-Centered Provider 103

GeriPal

MAY 18, 2023

And of course, take a deep dive by downloading the J AGS paper on the updated Beers Criteria or any of the great links from AGS including the: 2023 AGS Beers Criteria App Beers pocket card Transcript Eric: Welcome to the GeriPal podcast. So we want to alert clinicians as well as patients and policy makers to the presence of these drugs.

Medical 97

Medical IT Patients Clinic 97